Maze Therapeutics Inc
(MAZE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 12-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 29,158 | 99,919 |
| Other current assets | 0 | 0 | 4,952 | 6,230 |
| TOTAL | $0 | $0 | $34,110 | $106,149 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | 22,631 | 22,100 |
| Other Non-Current Assets | 0 | 0 | 2,410 | 0 |
| TOTAL | $N/A | $N/A | $25,041 | $22,100 |
| Total Assets | $0 | $0 | $71,504 | $149,957 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 2,019 | 0 |
| Accrued Expenses | 0 | 0 | 9,808 | 0 |
| TOTAL | $0 | $0 | $16,316 | $20,783 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 403,982 | 383,902 |
| TOTAL | $N/A | $N/A | $403,982 | $383,902 |
| Total Liabilities | $0 | $0 | $445,352 | $432,416 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 2 | 0 |
| Retained earnings | 0 | 0 | -395,686 | -295,271 |
| Other shareholders' equity | 0 | 0 | 0 | 12,812 |
| TOTAL | $0 | $0 | $-373,848 | $-282,459 |
| Total Liabilities And Equity | $0 | $0 | $71,504 | $149,957 |